Figures S1-S8 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

作者：Xiaoqing Cheng, Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou, Julie L. Prior, Ashley R. Tipton, Shunqiang Li, Anton Iliuk, Samuel Achilefu, Ian S. Hagemann, John R. Edwards, Ron Bose · 年份：2025 · DOI：10.1158/0008-5472.30701386 · 研究领域：PI3K/AKT/mTOR signaling in cancer、Advanced Breast Cancer Therapies、Cancer-related Molecular Pathways

Figures S1-S8

Figures S1-S8 from Breast Cancer Mutations &lt;i&gt;HER2&lt;sup&gt;V777L&lt;/sup&gt;&lt;/i&gt; and &lt;i&gt;PIK3CA&lt;sup&gt;H1047R&lt;/sup&gt;&lt;/i&gt; Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Figures S1-S8 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance